Search research articles
Contact Us
Filters
Showing results (611-620 of 647) with videos related to
Page
of 65
Sort By:
Nature Communications
|
May 3, 2023
Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lamblia
Albano H Tenaglia, Lucas A Luján, Diego N Ríos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
Keith C Bible, Vera J Suman, Michael E Menefee, et al.
Cancer Gene Therapy
|
January 7, 2021
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, Dhruva K Mishra, et al.
Proceedings. Biological Sciences
|
January 27, 2026
Global inequities in pesticide legislation: nearly half of pesticides approved in major crops in Latin America are not allowed in the European Union
Grecia Stefanía de Groot, Carolina Morales, Patricia Aldea-Sanchez, et al.
Journal of the National Cancer Institute
|
January 19, 2018
Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
Ting-Yuan David Cheng, Amy K Darke, Mary W Redman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
Keith C Bible, Vera J Suman, Julian R Molina, et al.
Cell Chemical Biology
|
March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants
Laurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2015
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Amita Patnaik, Paul Haluska, Anthony W Tolcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
R S Herbst, P Baas, J L Perez-Gracia, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
September 29, 2017
To which countries do European psychiatric trainees want to move to and why?
M Pinto da Costa, A Giurgiuca, K Holmes, et al.
Page
of 65
Search research articles
Search
Showing results (611-620 of 647) with videos related to
Sort By:
Page
of 65
Nature Communications
|
May 3, 2023
Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lamblia
Albano H Tenaglia, Lucas A Luján, Diego N Ríos, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer
Keith C Bible, Vera J Suman, Michael E Menefee, et al.
Cancer Gene Therapy
|
January 7, 2021
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, Dhruva K Mishra, et al.
Proceedings. Biological Sciences
|
January 27, 2026
Global inequities in pesticide legislation: nearly half of pesticides approved in major crops in Latin America are not allowed in the European Union
Grecia Stefanía de Groot, Carolina Morales, Patricia Aldea-Sanchez, et al.
Journal of the National Cancer Institute
|
January 19, 2018
Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
Ting-Yuan David Cheng, Amy K Darke, Mary W Redman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
Keith C Bible, Vera J Suman, Julian R Molina, et al.
Cell Chemical Biology
|
March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants
Laurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2015
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer
Amita Patnaik, Paul Haluska, Anthony W Tolcher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2019
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
R S Herbst, P Baas, J L Perez-Gracia, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
September 29, 2017
To which countries do European psychiatric trainees want to move to and why?
M Pinto da Costa, A Giurgiuca, K Holmes, et al.
Page
of 65